Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Case Studies in Health Administration|December 10, 1989
Case two. Development of a strategic plan and the planning process at a medical centerA C HolmScandinavian Journal of Clinical and Laboratory Investigation|April 1, 1987
Active transport of L-tri-iodothyronine through the red cell plasma membrane--true or false?A C HolmEuropean Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|December 1, 1995
Cortisol in saliva--reference ranges and relation to cortisol in serumE Aardal, A C HolmThe Journal of Clinical Endocrinology and Metabolism|August 1, 1989
Kinetics of triiodothyronine uptake by erythrocytes in hyperthyroidism, hypothyroidism, and thyroid hormone resistanceA C Holm, B KågedalActa Psychiatrica Scandinavica. Supplementum|January 1, 1990
Experiences of long-term treatment with remoxipride: efficacy and tolerabilityJ Wålinder, A C HolmJournal of Neural Transmission|January 1, 1980
Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesiaS O Ogren, A C HolmDrug Safety|June 1, 1993
Tolerability of remoxipride in the long term treatment of schizophrenia. An overviewA C Holm, I Edsman, T Lundberg, et al.Clinical Chemistry and Laboratory Medicine|June 25, 1998
Salivary cortisol--an alternative to serum cortisol determinations in dynamic function testsE Aardal-Eriksson, B E Karlberg, A C HolmActa Endocrinologica|May 1, 1977
Triodothyronine and thyroxine nuclear receptors in lyphocytes from normal, hyper- and hypothyroid subjectsT H Lemarchand-Béraud, A C Holm, B R ScazzigaJournal of Neural Transmission|January 1, 1984
Alaproclate, a new selective 5-HT uptake inhibitor with therapeutic potential in depression and senile dementiaS O Ogren, A C Holm, H Hall, et al.Pageof 2